Curtiss-Wright — Feb 14, 2024 release

I'm incredibly proud of the team's efforts to successfully execute our pivot to growth strategy and the momentum we now carry forward into 2024." "Looking ahead, our strong backlog entering the year supports our expectations to deliver total organic sales growth of 4% to 6% in 2024, including growth in all of our A&D and Commercial end markets. We expect to deliver continued operating margin expansion while increasing R&D investments, diluted EPS growth of 7% to 10%, and strong free cash flow generation ranging from $415 to $435 million. We remain well-positioned with strong alignment of our technologies to the favorable secular growth trends in each of our end markets, and confident in our ability to deliver profitable growth and drive long-term shareholder value." Fourth Quarter 2023 Operating Results (In millions) Q4-2023 Q4-2022 Change Reported       Sales $ 786   $ 758   4 % Operating income $ 161   $ 157   2 % Operating margin   20.4 %   20.8 % (40 bps)         Adjusted (1)       Sales $ 786   $ 758   4 % Operating income $ 163   $ 160   2 % Operating margin   20.8 %   21.1 % (30 bps) (1) Reconciliations of Reported to Adjusted operating results are available in the Appendix. Sales of $786 million increased 4% compared with the prior year period